The Uromigos

The Uromigos, Thomas Powles, MD, and Brian Rini, MD, FASCO, highlight the latest developments in genitourinary cancers. Each podcast episode features a guest expert from around the world discussing the latest data, debates, and manuscripts relevant to the practical clinical care of GU oncology patients.

ASCO GU
image header

View our exclusive coverage of The Uromigos Live & Unplugged in Nashville, Tennessee, held September 30 through October 1, including panel discussions with experts on kidney, prostate, and bladder cancers.

Advertisement

Latest Episode

Episode 215: Conversations & Trending Topics in GU Cancers: Prostate and Bladder Cancer Panel - Resumen Cáncer de Próstata y Vejiga Reunión Canarias
The Uromigos took part in the Conversations & Trending Topics in GU Cancers conference in the Canary Islands, where fellow oncologists Cris Suarez, Fernando Sabino, and Enrique Grande shared insights and opinions in the renal cancer space. ...
Advertisement

ESMO Coverage

Paper of the Month

Dr. Brian Rini’s Disclosures

Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Taris, Seattle Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics, Merck, Surface Oncology, Dragonfly Therapeutics, Aravive, Exelixis

Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Compugen, Merck, Corvus, Surface Oncology, 3DMedicines, Aravive, Alkermes, Arrowhead, GSK, Shionogi, Eisai

Stock: PTC therapeutics

Advertisement
Advertisement